Abstract
This article examines the molecular composition of amniotic fluid in pregnant women with COVID-19, emphasizing its effects on fetal growth and intrauterine circumstances. The research highlights the significance of amniotic fluid as a repository of essential biomarkers, examining alterations in hormone concentrations, metabolic byproducts, and stress-associated chemicals that may indicate the maternal-fetal reaction to viral infection. The research seeks to find significant patterns that may predict probable pregnancy issues, like intrauterine growth restriction or preterm labor, by the analysis of these modifications. The study elucidates how COVID-19 may disturb the biochemical equilibrium of the amniotic environment, offering insights into the virus's wider implications for pregnancy. These findings seek to facilitate the formulation of novel techniques for the surveillance and management of pregnancies complicated with COVID-19, hence improving maternal and newborn outcomes.